An Open-Label Safety Study of Lapatinib Plus Trastuzumab...

An Open-Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2-Positive Metastatic Breast Cancer

Esteva, F. J., Franco, S. X., Hagan, M. K., Brewster, A. M., Somer, R. A., Williams, W., Florance, A. M., Turner, S., Stein, S., Perez, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2012-0129
Date:
June, 2013
File:
PDF, 484 KB
english, 2013
Conversion to is in progress
Conversion to is failed